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Renal toxicity of phosphate in rats. To evaluate the mechanism
by which phosphate induces renal injury, we placed uni-
nephrectomized, partially nephrectomized, and intact rats on
dietary phosphorus intakes varying between 0.5 and 2% for 18
weeks. None of the animals on a normal phosphorus intake
(0.5%) had any abnormalities. Four out of six intact animals on a
1% phosphorus diet had kidney calcium concentrations within
the normal range, and only one showed any histologic changes.
In contrast, all but one partial and uninephrectomized animals
on a 1% phosphorus diet had increased kidney calcium content
concentration, and five of the six studied had histologic changes.
The degree of calcification and histologic changes in the uni-
nephrectomized animals on a 1% phosphorus diet was similar to
that found in the intact animals on a 2% phosphorus diet. Ani-
mals on a 3% phosphorus diet plus disodium ethane-l-hydroxy-
1-1-diphosphonate (EHDP) had significantly less calcification
and histologic changes than did animals on a similar diet without
EHDP. Conclusion. As renal functional mass is reduced, the
nephrotoxicity of phosphorus is greatly enhanced. Phosphorus-
induced renal injury is mediated through calcium phosphate
deposition in the kidney. This results from intrarenal causes, be-
cause the kidney calcification can be related to phosphate ex-
creted per functional unit rather than plasma phosphate concen-
trations.
La toxicité rénale du phosphate chez le rat. Pour évaluer le
mécanisme par lequel Ic phosphate determine des lesions ré-
nales, des rats uninéphrectomisés, partiellement néphrecto-
misCs, et intacts ont recu des apports de phosphate alimentaire
divers compris entre 0,5 et 2% pendant 18 semaines. Aucun des
animaux soumis a un apport de phosphorus normal (0,5%) n'a eu
d'anomalie. Quatre parmi les six animaux intacts soumis a un
apport de 1% avaient des concentrations rénales de calcium
comprises dans l'éventail des valeurs normales et seulement un
d'entre eux avait des lesions histologiques. Au contraire, les ani-
maux partiellement nephrectomisés ou uninéphrectomisés
soumis a un apport de 1% de phosphorus avaient tous, sauf un,
une augmentation du contenu renal en calcium. Cinq parmi les
six étudiés du point de vue histologique avaient des lesions.
L'importance de Ia calcification et des modifications histolo-
giques chez les animaux uninéphrectomisCs soumis a un apport
de 1% de phosphorus était comparable a celle observée chez les
animaux intacts soumis a un apport de 2% de phosphorus. Les
animaux soumis it un apport de 3% de phosphorus et a le di-
sodium ethane-l-hydroxy- 1- 1-diphosphonate (EHDP) avaient
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significativement moms de calcification et de modifications histo-
logiques que les animaux recevant Ia méme alimentation sans
EHDP. Conclusion. La reduction de Ia masse fonctionnelle ré-
nale augmente considérablement Ia toxicitC du phosphore.
L'atteinte renale liée au phosphore a pour médiateur Ia déposi-
tion de calcium phosphate dans le rein. Cela est Ia consequence
d'un mécanisme intra-rénal puisque Ia calcification est en
rapport avec l'excrétion de phosphore par unite fonctionnelle
plutôt qu'avec Ia concentration plasmatique de phosphore.
Several reports document the injurious effect of
high-phosphate intake on the kidney 11-4]. Largely,
it is assumed that calcium phosphate deposition
resulting from hyperphosphatemia incites an inflam-
matory and fibrotic response in a variety of organs,
explaining the mechanism of tissue injury [5, 6]. A
number of findings, however, suggest that the path-
ogenesis of renal injury from a high-phosphate diet
may be different. First, the histologic appearance
of the calcium phosphate deposits suggests they
result from intrarenal mechanisms [2]. Second, the
kidney calcifies early during the course of renal fail-
ure, prior to the time that plasma phosphorus con-
centrations are appreciably changed, whereas other
organs calcify in the terminal phase of renal failure
in association with markedly increased plasma
phosphorus concentrations [7, 8].
Phosphate-induced renal damage has assumed
increasing importance in view of the recent studies
that show that a phosphate-restricted diet fed
to animals with a remnant kidney [9] or ex-
perimental glomerulonephritis [10] prevents cal-
cification, functional deterioration, and histologic
changes.
The mechanism by which phosphate restriction
prevents progressive destruction of the diseased or
damaged kidney has not been defined. It is known,
however, that with both increased phosphorus in-
takes [11—13] and reduction of functional renal mass
[14] that adaptive mechanisms are brought into
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play, which are not necessarily dependent on PTH,
to maintain phosphate balance. It seems possible
that this adaptive mechanism that results in an in-
creased phosphate excretion per nephron could be
responsible for the calcium phosphate deposition
and renal injury.
The purpose of this study was to test whether in-
creased renal excretion of phosphorus could induce
renal calcification and injury in the absence of a rise
in plasma phosphorus concentration. By surgical
procedures, we removed various fractions of the
renal mass and nephron population. We then gave
the animals normal to elevated phosphate intake, so
as to widely vary phosphate load excreted per neph-
ron without changing plasma phosphate concen-
trations. To determine if phosphate renal injury
was mediated through calcification or phosphate
loads themselves, we gave the animals diphospho-
nates to decrease the severity of the calcium phos-
phate deposits while maintaining a high renal phos-
phate load.
Methods
Fifty-four male Sprague Dawley rats (Simonson
Labs, Gilroy, California), each weighing between
200and 250 g, were divided into throe groups (1,2,
and 3) of 18 animals each. Each group was evenly
divided into three subgroups: A, B, and C. Animals
in subgroup A were left intact. Animals in sub-
groups B (partial nephrectomy) had the outer poles
of the left kidney removed by ligation and cautery
as previously described [9], but the contralateral
kidney was left intact. Animals in subgroup C (uni-
nephrectomy) underwent a left nephrectomy. All
operations were performed through a flank incision,
after the rats were anesthetized with ether. Immedi-
ately postoperatively, the animals were begun on
their experimental diets (vide infra).
They were fed a synthetic low-phosphorus diet
(ICN Pharmaceuticals Incorporated, Cleveland,
Ohio) to which a balanced phosphorus mixture
(four parts monobasic sodium phosphate; one part
diabasic sodium phosphate) was added to make a
0.5% phosphorus diet (group 1), a 1.0% phosphorus
diet (group 2), and a 2% phosphorus diet (group
3). The diet was fully fortified with vitamins and
contained 20% protein (bovine fibrin). On analysis,
it contained 0.56% calcium, 0.02% magnesium,
and 0.04% phosphorus before supplementation.
Throughout the study period, animals in all groups
received and consumed an equal amount of food
(approximately 10 g!day).
Immediately prior to surgery and to beginning the
experimental diets, we drew control blood samples
for creatinine, calcium, and phosphorus by per-
cutaneous cannulation of the tail artery. After be-
ginning the experiment we obtained blood samples
for chemical analysis at 3-week intervals.
At 7 weeks into the study, four animals from each
group were placed overnight into individual stain-
less steel wire mesh metabolic cages. Starting the
next morning, we gathered two consecutive 24-hour
urine collections for measurement of volume,
creatinine, calcium, and phosphorus. Each animal
was given 10 g of food each day, which was always
fully consumed. Blood samples were drawn from
the animals upon completion of the urine collec-
tions.
At 18 weeks into the study, the animals were
weighed and lightly anesthetized with ether, and
their blood pressures were directly measured by
cannulating their abdominal aortas with a 20-gauge
needle connected to a transducer (Statham model-
P23D, Statham Medical Instruments, Inc., Hato
Rey, Puerto Rico). The pressures were recorded on
a recorder (Model 7702B, Hewlett-Packard, Wal-
tham, Massachusetts). Next, the animals were ex-
sanguinated via the aortic needle and the blood was
collected for chemical analysis An additional 18
rats were killed after they had received the diet for
10 weeks. Six intact animals and six uni-
nephrectomized animals had received the 1% phos-
phorus diet, and six intact animals had ingested the
2% phosphorus diet for this 10-week period. The
kidneys were removed and weighed, and a coronal
section of each kidney was immediately fixed in
10% buffered formalin for histology. The remainder
of the kidney tissue, as well as a section of the
aorta, was dried and analyzed for calcium content
by previously reported techniques [5].
Serum and urine samples were analyzed on an
autoanalyzer (Technicon II) for creatinine [15].
Phosphorus was measured with an automated modi-
fication of the method of Fiske and Subbarow [16],
and calcium was measured with an atomic absorp-
tion spectrophotometer (Perkin Elmer, model
290B), as previously described [5].
Kidney sections were stained with hematoxylin
and eosin. Slides from the intact and nephrecto-
mized groups were coded and given to an experi-
enced renal pathologist, who read the slides without
knowledge of the code. The slides were evaluated
for histologic severity of disease from zero (no ab-
normality) to 3 + (marked abnormality). The histo-
logic severity index was the mean grade of the fol-
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lowing parameters, each of which was individually
scored: interstitial edema, interstitial infiltrate, in-
terstitial fibrosis, tubular atrophy, and tubular dila-
tation.
Statistical comparisons were performed with un-
paired Student's t test, except where otherwise
stated. All values are expressed as the means
SEM.
Diphosphonare study. Ten male Sprague Dawley
rats, each weighing between 275 and 325 g, were
evenly divided into two groups (A and B). While
receiving standard Purina rat chow, the animals
in group A were given a daily i.p. injection
of disodium ethane- I -hydroxy- I- 1-diphosphonate
(EHDP) in saline (supplied by Procter and Gamble)
at a dose of 5 mg/kg for 10 days.
After the initial 10 days, the animals in both
groups were placed on the experimental diet. The
experimental diet was finely ground Purina rat
chow, to which the balanced phosphorus mixture
(vide supra) was added to make a 3% phosphorus
diet. The diet was fully fortified with vitamins and
contained 24% protein. On analysis, it contained
1.5% calcium, 0.2% magnesium, and 0.5% phos-
phorus before supplementation.
The animals were fed the experimental diet twice
daily, at 8:00 A.M. and 4:00 P.M. Each feeding con-
sisted of 10 g/rat. Immediately prior to each feeding,
the five animals in group A each received an i.p.
injection of EHDP in saline for a total daily dose of
10 mg/kg. Whether or not the food was completely
consumed, the food dishes were removed from the
cage after 4 hours at each feeding. This method of
feeding was carried out to insure that the animals
had maximum urine and plasma diphosphonate con-
centrations during the time they were ingesting
phosphate.
Blood samples were obtained for creatinine and
phosphorus by tail artery cannulation at the begin-
ning of the study and at 1 to 2-week intervals there-
after. At 1 week and at 5 weeks after starting the 3%
phosphorus diets, the animals were placed in meta-
bolic cages overnight, and starting the next morning
they had two consecutive 24-hour urine collections
for measurement of volume, creatinine, and phos-
phorus.
At 6 weeks, both groups were bled for chemical
analysis, and all animals underwent a left nephrec-
tomy under ether anesthesia. The kidneys were
weighed, and a coronal section of each was immedi-
ately fixed in 10% buffered formalin for histology.
The remainder of the kidney was dried and ana-
lyzed for calcium content (vide supra).
Results
The study was designed to end when one or more
groups developed uremia, as defined by a plasma
creatinine concentration greater than 1 mg/dl. This
occurred at 18 weeks.
The results of the metabolic studies carried out at
week 7 are shown in Table 1. Urinary phosphorus
excretion reflected the phosphorus intake in all
groups of animals. Phosphorus excretion was simi-
lar in animals maintained on a similar phosphorus
intake, whether they were intact, partially nephrec-
tomized, or uninephrectomized. Considerable func-
tional hypertrophy had occurred as evidenced by
the fact that the mean creatinine clearance was only
slightly less in the uninephrectomized and partially
Table 1. Seven-week balance studya
Groupb
Dietary P
mg/day
Ccr
,nl/rnin//OO g
body u't
Urinary P
,ng/day
P load excreted
per nephron
pg/day
Urinary
Ca)< P
(mg/d/)2
Group 1(0.5% P)
A 50 0.55 0.04 31.0 1.3 0.52 0.02 195 36
B 50 0.57 0.03 30.0 2.1 — 163 25
C 50 0.47 0.03 31.0 1.3 1.04 0.04 283 115
Group 2(1.0% P)
A 100 0.53 0.08 72.0 1.1 1.20 0.02 354 64
B 100 0.51 0.05 64.0 3.3 — 379 38
C 100 0.49 0.04 64.0 6.5 2,14 0.22 379 79
Group 3 (2.0% P)
A 200 0.48 0.05 150.0 19.4 2.51 0.32 702 84
B 200 0.37 0.03 144.0 9.8 — 498 34
C 200 0.42 0.03 152.0 12.6 5.07 0.42 742 78
Values are the means SEM.
b Subgroups are designated as A, intact kidneys; B, partial nephrectomy; C, uninephrectomy.
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nephrectomized groups than it was in the intact
groups.
The average phosphorus load to be excreted per
nephron was calculated, assuming 3 X 10 nephrons
per rat kidney. This calculation was not performed
for the partial nephrectomy groups, because the ex-
act amount of renal tissue removed was unknown.
As can be appreciated in Table 1, uninephrecto-
mized animals on a 0.5% phosphorus diet had a
phosphorus excretion per nephron similar to the
intact animals on 1% phosphorus diet, and the
uninephrectomized animals on a 1% phosphorus
diet had a phosphorus excretion per nephron similar
to intact animals on a 2% phosphorus diet. The uri-
nary calcium-times-phosphorus products increased
with every dietary increment of phosphorus, but
showed little intragroup variation.
Serial plasma phosphorus concentrations ob-
tained throughout the study are shown in Fig. I (in-
tact animals), Fig. 2 (animals with partial nephrec-
tomy), and Fig. 3 (animals with unilateral nephrec-
tomy). Throughout the study period, plasma
phosphorus concentrations were similar in the ani-
mals on 0.5% and 1% phosphorus diets in all the
subgroups (Figs. 1 to 3). In the intact animals on 2%
phosphorus, plasma phosphorus showed no consis-
tent difference until 14 weeks, when the phosphorus
increased and remained higher at 16 and 18 weeks,
although the difference from the other groups fell
short of significance. The same pattern was ob-
served in the uninephrectomized and partially ne-
phrectomized animals on the 2% phosphorus diet.
These groups had a more marked elevation of phos-
phorus at 14 weeks, which persisted at significantly
higher values (P < 0.001) than it did in the other
groups at each subsequent determination (Figs. 2
and 3).
During the latter half of the study, plasma cal-
cium concentrations were significantly less in ani-
mals with reduced renal mass on 2% phosphorus
diet as compared with the other two groups. Ani-
mals on 0.5% and 1% phosphorus diet had similar
calcium concentrations throughout the study period
with the exception of the final values obtained at 18
weeks, which were 10.5 0.08 in group 1 vs. 9.5
0.15 in group 2 (P <0.001) and 8.2 0.65 mg/dl in
group 3 (P < 0.005).
At 18 weeks, group 3C (2% phosphorus, one kid-
ney) became uremic with a mean plasma creatinine
concentration of 1.08 0.12, which was significant-
ly elevated (P < 0.001) as compared with the con-
trol group 1A (0.5% phosphorus with two kidneys)
(0.48 0.02). Group 3B (2% phosphorus, partial ne-
.—, 0.5% Phosphorus diet
— - 1.0% Phosphorus diet
2.0% Phosphorus diet
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Fig. 1. Serial plasma phosphorus concentrations in the intact
rats in groups 1, 2, and 3.
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Fig. 2. Serialplasma phosphorus concentrations in the partially
nephrectoinized rats in groups I, 2, and 3.
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Fig. 3. Serial plasma phosphorus concentrations in the uni-
nephrectomized rats in groups 1, 2, and 3.
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Table 2. Histologic and analytical dataa
Grouph
Histologic
severity
index
Quantity, mmoles/kg DDFT Animal's
final weight
gCa P
Group 1(0.5% P)
A 0 13.7 1.2 335 6 393 7
B — 13.7 2.0 354 12 389 15
C 0 12.8 1.7 359 7 365 12
Group 2(1.0% P)
A 0.1 0.1 60 37 360 7 367 12
B — 147 83 417 37 327 9
C 1.1 0.3 589 417 654 222 342 23
Group 3 (2.0% P)
A 1.6 0.1 431 40 700 154 365 30
B — 2124 555 1457 323 265 22
C 2.6 0.1 2252 501 1393 241 271 10
a Values are the means SEM. DDFT is dry defatted tissue.
' Subgroups are defined in Table 1.
phrectomy) also had plasma creatinine concentra-
tions (0.97 0.14) that were significantly higher
than those of group 1A (P < 0.005). At this time,
mean plasma creatinine concentration in no other
group was significantly different from that of group
1A. In addition, plasma creatinine in every animal
of the other groups was within the normal range for
our lab, except for one animal in group 2C (1%
phosphorus, one kidney), which had a creatinine of
1.7 mg/dl at sacrifice.
There was no significant difference in blood pres-
sure among the groups at sacrifice.
Table 2 includes the mean histologic severity in-
dex, kidney calcium and phosphorus content, and
animal weight for each of the nine subgroups.
Animal weights were similar in all groups, except
for the uninephrectornized and partially nephrecto-
mized animals on the 2% phosphorus diet, which
were lower than the others (Table 2).
All animals in group 1 (0.5% phosphorus) had
similar kidney calcium concentrations, which were
in the normal range for our lab, and none had histo-
logic evidence of damage.
In group 2 (1% phosphorus), only two of the six
animals in the intact group had kidney calcium con-
centrations outside of the normal range, and only
one of these animals had any histologic evidence of
damage (Fig. 4). In contrast, all but one kidney from
the partial nephrectomized and uninephrectomized
groups contained increased calcium concentration,
and all five animals in the uninephrectomized group
with elevated kidney calcium concentrations had
histologic evidence of disease. Because of the lack
of a normal distribution of the data, the difference in
calcification between the intact group and the
groups with renal mass removed was not significant
with standard statistical methods. Significance was
achieved, however, with the Wilcoxon rank sum
method for nonparametric data (P < 0.05) or by
comparing log10 of the calcium concentrations (P <
3000i 3.
2000
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Intact PartaI IJninephrectomy Intact IJninephrectomy
Fig. 4. Kidney calcium content in all animals in group 2 (1% P diet) and histologic severity index in animals from subgroups A and C.
Only five animals are shown in group B as a result of one animal escaping from his metabolic cage prior to completion of the study. The
symbol t indicates the single animal with an elevated plasma creatinine concentration.
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Fig. 5. Histology of a kidney obtained from an animal in group 3C, demonstrating calcium phosphate deposit, interstitial fibrosis.
tubular dilatation, and inflammatory cell infiltration.
0.05). In addition, the histologic severity index was
significantly higher in the uninephrectomized ani-
mals of group 2 as compared to the intact animals in
that group (P < 0.025) (Fig. 4).
All animals in group 3 (2% phosphorus diet) had
marked histologic evidence of disease and in-
creased kidney calcium content. The uni-
nephrectomized and partially nephrectomized ani-
mals on the 2% diet had significantly more calcifica-
tion (P < 0.01 and <0.025. respectively) than did
the intact animals on the 2% diet. In addition, the
uninephrectomized animals on this diet had a signif-
icantly higher histologic severity index (P < 0.001)
than did the intact animals on this diet. Kidney
phosphorus concentration rose in association with
kidney calcium, supporting the deposition of a cal-
cium phosphate compound (Table 2).
The histologic damage was limited to the inter-
stitium and tubules. At the high phosphate loads
per nephron, there was marked interstitial edema,
fibrosis, and mononuclear cell infiltration. There
was also tubular atrophy and dilatation. Calcifica-
tion was most prominent in tubular lumens in the
vicinity of the corticomedullary junction. There was
some calcium in the interstitium, although much of
the interstitial calcification could have originated in
the tubules that subsequently degenerated. In some
severely affected tubules, there appeared to be cal-
cification of the tubular epithelial cells. An example
of the histologic damage is shown in Fig. 5, which is
from a uninephrectomized animal on a 2% phos-
phorus intake.
The histologic severity index and the kidney cal-
cium concentration correlated extremely well for all
animals in groups A and C (r = 0.84) (P <0.01).
There was also a good correlation between net
kidney weight and kidney calcium concentrations
for animals in each subgroup at all dietary levels of
phosphorus; subgroup A (intact), r = 0.87; sub-
group B (partial nephrectomy), r = 0.86; subgroup
C (uninephrectomy), r = 0.88.
There was a highly significant correlation (r
= 0.87, P < 0.01) between phosphate load excreted
per nephron and histologic severity index (Fig. 6).
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Calcification of the aorta did not occur unless the
animal had marked renal impairment, with eleva-
tion of the calcium-times-phosphorus product. In
contrast, the kidney calcified in the absence of ure-
mia at a time when the calcium-times-phosphorus
product was normal. This is demonstrated in Fig. 7,
in which the aortic and kidney calcium concentra-
tions of the uninephrectomized groups on all three
diets are shown. Four of six animals on 1% phos-
phorus had elevated kidney calcium concentrations
with either normal or minimally elevated aortic cal-
cium concentrations. The one uremic animal in this
group had markedly elevated calcium concentra-
tions in both organs. To exclude the possibility that
a modest rise in plasma phosphorus levels and func-
tional deterioration were responsible for some of
the changes noted, we killed 18 animals after they
received the phosphorus-supplemented diet for on-
ly 10 weeks. The six intact animals maintained on a
1% phosphorus diet had no renal histologic
changes, and kidney calcium concentration (12.7
0.41 mmoles/kg of dry wt) was within the normal
range. In contrast, uninephrectomized animals on a
1% phosphorus diet had a kidney calcium concen-
A
I I — I — I I I I I123456123456123456
Animal number
Fig. 7. Calcium concentrations in aorta and kidney from all uni-
nephrectomized animals in the three groups.
tration of 80 34 mmoles/kg and a histologic sever-
ity index of 0.70 0.22, and intact animals on a 2%
phosphorus diet had a kidney calcium concentra-
tion of 557 110 and a histologic severity index of
1.8 0.17. No animal in either of these groups was
uremic or had elevated plasma phosphorus concen-
trations at any time during the 10-week study. The
final plasma phosphorus concentration was 6.27
0.29 and 5.55 0.20 mg/dl, and creatinine was 0.59
0.02 and 0.52 0.02, respectively, in these two
groups of animals.
EHDP. Table 3 shows the mean values for
weights, creatinine clearance per 100 g body wt,
and urinary phosphorus excretion at 1 week and at 5
weeks into the study. In addition, plasma phosphate
concentrations are shown at 1 week, 3 weeks, and 5
weeks. There was no significant difference between
the groups in animal weights, creatinine clearance
per 100 g of body wt, or urinary phosphorus excre-
Table 3. Diphosphonate (EHDP) balance dataa
Cçr
Weight ml/min//OO g Urine P P.
Time Group g body wt mg/day mg/dl
1 week A (3% P + EHDP)
B (3% P)
P
308 12
299 5
NS
0.42 0.03
0.42 0.07
NS
132 9
142 4
NS
7.28 0.42
9.24 0.98
NS
3 weeks A
B
P
336 14
331 14
NS
—
—
—
9.04 0.71
9.60 1.02
NS
5 weeks A
B
P
333 16
340 15
NS
0.49 0.06
0.47 0.03
NS
206 26
192 20
NS
7.72 0.35
11.1 1.12
<0.025
a Values are the means SEM. Diphosphonate is disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP).
3
x
a)002>
a)>
a,
C,
a,0
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1.0 2:0 3.0 4.0 5.0 6.0 7.0
Phosphate load excreted per nephron, pg/day
Fig. 6. Correlation between phosphate load excreted per neph-
ron measured at the week 7 and histologic severity index deter-
mined at the conclusion of the study (week /8).
= 0.87
p<0.01
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Table 4. Diphosphonate (EHDP) histologic and analytical data
Quantative
Group
Animal
no.
Wet kidney
wt
g
Histologic
severity
index
calcification
mmoleslkg
DDFT
Scr
ingidi
A(3% P + EHDP) 1
2
3
4
5
2.04
1.61
2.16
1.63
2.08
0.8
0.8
1.0
0.2
0.8
237
83
266
116
85
0.45
0.45
0.50
0.50
0.40
Mean SEM 1.90 0.12 0.72 0.14 157 39 0.46 0.02
B (3% P, no EHDP) 1
2
3
4
5
2.71
2.82
2.88
2.47
2.57
2.2
2.0
2.6
2.0
1.4
489
303
384
367
151
0.95
0.50
0.85
0.45
0.45
Mean±sEM 2.69 0.08 2.04 0.19 339 56 0.64 0.11
P <0.001 <0.001 <0.05 NS
DDFT is dry defatted tissue.
tion. The mean plasma phosphate concentration
was significantly higher in the group not on EHDP
only at the 5-week sample (P < 0.025).
Table 4 shows data obtained at the end of the
study (6 weeks). Group B, which did not receive
EHDP, had a significantly higher wet kidney weight
(P < 0.001), a significantly higher histologic severi-
ty index (P < 0.001), and a significantly higher kid-
ney calcium content (P < 0.05). The creatinine con-
centrations were not significantly different between
the groups, but the two animals with the highest his-
tologic severity index (B! and B3) had creatinine
values above the range of normal for our lab. There
was excellent correlation (r =0.83) between the cal-
cium concentration of the kidneys and the histolog-
ic severity index.
Discussion
This study confirms earlier reports showing that
extremely high phosphate diets cause renal disease
in normal animals [1-4]. It is also apparent, how-
ever, that as renal mass is reduced, renal injury is
intensified, and less phosphate intake is required to
induce renal injury. Animals receiving a 2% phos-
phorus diet with both kidneys intact have no change
in renal function, whereas uninephrectomized and
partial nephrectomized animals on a similar diet un-
dergo a marked functional deterioration during the
study period. Furthermore, in animals with only
one kidney, a phosphorus intake two times normal
for the rat (1% phosphorus) causes marked calcifi-
cation and histologic changes in the remaining kid-
ney, whereas animals with two kidneys tolerate this
amount of phosphorus reasonably well. These stud-
ies further suggest that renal injury is directly a con-
sequence of the intrarenal phosphate load, in that
animals with one kidney on a 1% phosphorus diet
who have marked histologic alterations in the kid-
ney have plasma phosphorus concentrations similar
to uninephrectomized animals on a 0.5% diet who
have no renal injury. In fact, even uninephrec-
tomized animals on 2% phosphorus diets tend to
have normal phosphorus concentrations until func-
tional impairment occurs. In addition, animals
killed at 10 weeks, prior to the time that plasma
phosphorus increases in any group, also have ex-
tensive renal calcification and histologic changes.
Thus, it would appear that the nephrotoxicity of
phosphorus is markedly increased as renal function-
al mass is decreased. This is graphically displayed
in Fig. 8. In animals with 100% of renal mass, tox-
icity occurs when phosphorus intake is increased
four times normal, whereas animals with 50% re-
duction in mass develop a comparable degree of
toxicity when dietary phosphorus is increased only
twofold. With further reduction in renal mass, as
found in the remnant kidney model, toxicity occurs
at normal phosphorus intake [9]. These observa-
tions may explain the progressive functional deteri-
oration that occurs when a critical amount of renal
tissue is removed in the rat and possibly other spe-
cies [17—19]. In support of this is the fact that func-
tional deterioration in rats with a remnant kidney
can be prevented by phosphorus restriction [9].
In the present study, as well as in animals with
the renal remnant, there are increased GFR and
filtered load of phosphorus per nephron. In experi-
mental glomerulonephritis, however, where single
nephron GFR and filtered load of phosphorus may
be normal or reduced, kidney calcification also oc-
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Fig. 8. Renal toxicity of phosphate in regards to dietary intake
and amount of functional renal tissue.
curs [10]. This suggests that an increased filtered
load of phosphorus may not be the entire mecha-
nism responsible for renal calcification.
It has been shown that during chronic oral phos-
phate loading there is a marked adaptation, only
partially mediated through parathyroid hormone,
for increasing phosphorus excretion [11-13]. In addi-
tion, in the adaptive state, tubular secretion of
phosphorus has been shown [20]. Thus, it may be
that these adaptive mechanisms that would be ex-
pected to be present in renal failure as well as dur-
ing phosphate loading could be injurious to the kid-
ney, promoting calcium phosphate deposition,
which in turn incites an inflammatory and fibrotic
response.
These studies would further support the con-
tention that phosphate-induced renal injury is medi-
ated through calcification. First, there is a strong
correlation between the degree of calcification and
severity of histologic injury (r = 0.84). Second, ani-
mals given EHDP have significantly less renal histo-
logic injury as compared with animals receiving a
comparable phosphate intake without EHDP.
EHDP could affect calcium phosphate deposits in
two ways. First, it would tend to prevent the forma-
tion of apatite or brushite [2 1—23]; and second, it
would prevent the transformation of amorphous de-
posits to crystalline deposits [24]. The most appar-
ent reason that EHDP has a protective effect is that
it reduces the intensity of renal calcification.
Because the animals not receiving EHDP have
significantly higher plasma phosphorus concentra-
tions, it seems possible that this might also contrib-
ute to the increased kidney calcium content. But, as
stated above, in the other groups of animals, kidney
calcium content bears no relationship to plasma
phosphorus concentrations.
The mechanism responsible for the phosphate-in-
duced intrarenal calcification is not readily appar-
ent. High intratubular phosphate concentrations
could result in precipitation of calcium phosphate
in the tubular lumen, possibly in association
with change in tubular fluid pH. Second, MacKay
and Oliver have suggested that high phosphorus
loads are a direct toxin to the renal tubular cells [1].
In turn, dystrophic calcification could occur as a re-
sult of cellular injury. PITH could also play a role in
the pathogenesis of the renal calcification, because
it would be expected that animals on high phos-
phate diets would have elevated PTH levels, and
P1'H has been implicated in other forms of extra-
skeletal calcilIcations [25]. A fourth possibility,
metastatic calcification, as stated above, seems un-
likely because serum phosphorus concentrations
bear no relationship to kidney calcium content. In
contrast to kidney tissue, other soft tissues (aortic)
did not undergo calcification until the animal be-
came uremic and had marked hyperphosphatemia.
Also, the animals killed at 10 weeks, prior to having
any elevation in plasma phosphorus concentrations,
have extensive renal calcification and histologic al-
terations.
We conclude that as renal functional mass is re-
duced, the renal toxicity of phosphorus is enhanced.
Toxicity of phosphorus appears to be largely medi-
ated through calcification. Until more is known in
regards to phosphate toxicity in other species, it
seems prudent to use phosphorus therapy with ex-
treme caution in patients with even modestly re-
duced renal function. In addition, these observa-
tions may prove relevant to chronic forms of renal
disease in which phosphate restriction may slow
functional deterioration.
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